Lon Peptidase 1 (LONP1)-dependent Breakdown of Mitochondrial 5-Aminolevulinic Acid Synthase Protein by Heme in Human Liver Cells

被引:106
|
作者
Tian, Qing [2 ]
Li, Ting [2 ]
Hou, Weihong [2 ]
Zheng, Jianyu [2 ]
Schrum, Laura W. [2 ,3 ]
Bonkovsky, Herbert L. [1 ,2 ,3 ,4 ,5 ]
机构
[1] Carolinas Med Ctr, Cannon Res Ctr, Liver Digest & Metab Disorders Lab, Charlotte, NC 28203 USA
[2] Carolinas Med Ctr, Liver Biliary Pancreat Ctr, Charlotte, NC 28203 USA
[3] Univ N Carolina, Dept Biol, Charlotte, NC 28223 USA
[4] Univ Connecticut, Ctr Hlth, Dept Med, Farmington, CT 06030 USA
[5] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA
基金
美国国家卫生研究院;
关键词
DELTA-AMINOLEVULINATE SYNTHASE; MESSENGER-RNA; DEGRADATION; TRANSCRIPTION; EXPRESSION; REPRESSION; PORPHYRIA; GENE;
D O I
10.1074/jbc.M110.215772
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
5-Aminolevulinic acid synthase (ALAS-1) is the first rate controlling enzyme that controls cellular heme biosynthesis. Negative feedback regulation of ALAS-1 by the end product heme is well documented and provides the foundation for heme treatment of acute porphyrias, a group of diseases caused by genetic defects in the heme biosynthesis pathway and exacerbated by controlled up-regulation of ALAS-1. Heme is known to affect ALAS-1 activity by repressing gene transcription, accelerating mRNA degradation, and impeding pre-ALAS-1 mitochondrial translocation. In the current study, we examined the effect of heme on the rate of mature ALAS-1 protein turnover in human cells and tissues and explored the mediator involved in this new regulatory mechanism. We found that heme and other metalloporphyrins such as CoPP and CrPP decreased mitochondrial ALAS-1 protein through proteolysis. This degradative effect cannot be emulated by iron or free protoporphyrin, two major chemical components of the heme ring, and is independent of oxidative stress. Down-regulating the activity of mitochondrial LONP1, an ATP-dependent protease that controls the selective turnover of mitochondrial matrix proteins, with potent inhibitors and specific siRNA diminished the negative effect of heme on mitochondrial ALAS-1. Therefore, our data support the existence of a conserved heme feedback regulatory mechanism that functions on the mature form of ALAS-1 protein through the activity of a mitochondrial proteolytic system.
引用
收藏
页码:26424 / 26430
页数:7
相关论文
共 50 条
  • [21] eEF1A1 binds and enriches protoporphyrin IX in cancer cells in 5-aminolevulinic acid based photodynamic therapy
    Zhichao Fan
    Xiaojun Cui
    Dan Wei
    Wei Liu
    Buhong Li
    Hao He
    Huamao Ye
    Naishuo Zhu
    Xunbin Wei
    Scientific Reports, 6
  • [22] eEF1A1 binds and enriches protoporphyrin IX in cancer cells in 5-aminolevulinic acid based photodynamic therapy
    Fan, Zhichao
    Cui, Xiaojun
    Wei, Dan
    Liu, Wei
    Li, Buhong
    He, Hao
    Ye, Huamao
    Zhu, Naishuo
    Wei, Xunbin
    SCIENTIFIC REPORTS, 2016, 6
  • [23] Effects of photoactivated 5-aminolevulinic acid hexyl ester on MDR1 over-expressing human uterine sarcoma cells
    Chu, Ellie S. M.
    Yow, Christine M. N.
    Shi, Mark
    Ho, Rodney J. Y.
    TOXICOLOGY LETTERS, 2008, 181 (01) : 7 - 12
  • [24] Subcellular localization of 5-aminolevulinic acid mediated photodynamic therapy results in differential phototoxicity in human lung adenocarcinoma CL1 cells
    Tsai, T
    Li, WL
    Tsai, JC
    Chen, CT
    LASERS IN SURGERY AND MEDICINE, 2005, : 64 - 64
  • [25] 5-Aminolevulinic Acid-Mediated Sonodynamic Therapy Inhibits RIPK1/RIPK3-Dependent Necroptosis in THP-1-Derived Foam Cells
    Tian, Fang
    Yao, Jianting
    Yan, Meng
    Sun, Xin
    Wang, Wei
    Gao, Weiwei
    Tian, Zhen
    Guo, Shuyuan
    Dong, Zengxiang
    Li, Bicheng
    Gao, Tielei
    Shan, Peng
    Liu, Bing
    Wang, Haiyang
    Cheng, Jiali
    Gao, Qianping
    Zhang, Zhiguo
    Cao, Wenwu
    Tian, Ye
    SCIENTIFIC REPORTS, 2016, 6
  • [26] 5-Aminolevulinic Acid-Mediated Sonodynamic Therapy Inhibits RIPK1/RIPK3-Dependent Necroptosis in THP-1-Derived Foam Cells
    Fang Tian
    Jianting Yao
    Meng Yan
    Xin Sun
    Wei Wang
    Weiwei Gao
    Zhen Tian
    Shuyuan Guo
    Zengxiang Dong
    Bicheng Li
    Tielei Gao
    Peng Shan
    Bing Liu
    Haiyang Wang
    Jiali Cheng
    Qianping Gao
    Zhiguo Zhang
    Wenwu Cao
    Ye Tian
    Scientific Reports, 6
  • [27] 5-Aminolevulinic acid sonodynamic therapy in recurrent glioblastoma: A first-in-human phase 0/1 clinical trial
    Sanai, N.
    Tien, A-C.
    Tovmasyan, A.
    Chang, Y-W.
    Margaryan, T.
    Hendrickson, K.
    Eschbacher, J.
    Yoo, W.
    Harmon, J.
    Quarles, C.
    Alhilali, L.
    Barani, I.
    Mehta, S. N.
    Mirzadeh, Z.
    ANNALS OF ONCOLOGY, 2021, 32 : S518 - S519
  • [28] Photodynamic processes and the synthesis of 5-aminolevulinic acid in chlorella cells treated with amino acids and 1,10-phenanthroline
    T. V. Samovich
    N. V. Shalygo
    A. P. Kudryashov
    N. G. Averina
    Russian Journal of Plant Physiology, 2006, 53 : 814 - 823
  • [29] A FIRST-IN-HUMAN PHASE 0/1 CLINICAL TRIAL OF 5-AMINOLEVULINIC ACID SONODYNAMIC THERAPY IN RECURRENT GLIOBLASTOMA
    Sanai, Nader
    Tien, An-Chi
    Tovmasyan, Artak
    Chang, Yu-Wei
    Margaryan, Tigran
    Hendrickson, Kristin
    Eschbacher, Jennifer
    Yoo, Wonsuk
    Harmon, Jocelyn
    Quarles, Christopher
    Alhilali, Lea
    Barani, Igor
    Mehta, Shwetal
    Mirzadeh, Zaman
    NEURO-ONCOLOGY, 2021, 23 : 64 - 64
  • [30] Photodynamic processes and the synthesis of 5-aminolevulinic acid in chlorella cells treated with amino acids and 1,10-phenanthroline
    Samovich, T. V.
    Shalygo, N. V.
    Kudryashov, A. P.
    Averina, N. G.
    RUSSIAN JOURNAL OF PLANT PHYSIOLOGY, 2006, 53 (06) : 814 - 823